Needham maintains Biogen (NASDAQ:BIIB) $320 price targetBy legume / July 26, 2023 / Biogen, Needham Needham analyst Ami Fadia reiterates Biogen (NASDAQ:BIIB) with a Buy and maintains $320 price target.